
Pfizer (NYSE: PFE) has announced that the European Medicines Agency has accepting the marketing authorisation application for its meningococcal group …

Novartis will have to significantly lower the price of its meningococcal B vaccine if it wants a lucrative UK inoculation …
Novartis has submitted its meningococcal vaccine Bexsero to European regulators for marketing approval. If approved the drug will be the …

